Jury Awards $225K For Jaw Decay From Novartis Bone Drug

Law360, New York (April 9, 2012, 3:22 PM EDT) -- A federal jury in Missouri on Friday awarded $225,000 to a woman claiming Novartis Pharmaceuticals Corp.'s bone drug Zometa caused her mother's jaw disease, unanimously finding the drugmaker negligently failed to warn doctors about the drug's dangers.

After a little more than a day of deliberations, the jury told Novartis to pay compensatory damages to plaintiff Christine Winter but turned down her request for $7.5 million in punitive damages, according to Hollingsworth LLP, a firm representing Novartis.

John Beins, a Beins Goldberg & Hennessey LLP attorney...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Winter v. Novartis Pharmaceuticals Corporation


Case Number

2:06-cv-04049

Court

Missouri Western

Nature of Suit

Personal Inj. Prod. Liability

Judge

Matt J. Whitworth

Date Filed

March 14, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.